Darya Chudova - 01 Feb 2025 Form 4 Insider Report for Guardant Health, Inc. (GH)

Role
Chief Technology Officer
Signature
/s/ John G. Saia, as attorney-in-fact for Darya Chudova
Issuer symbol
GH
Transactions as of
01 Feb 2025
Net transactions value
-$392,377
Form type
4
Filing time
04 Feb 2025, 17:14:52 UTC
Previous filing
03 Jan 2025
Next filing
04 Mar 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GH Common Stock Options Exercise $0 +21,863 +39% $0.000000 78,416 01 Feb 2025 Direct
transaction GH Common Stock Tax liability $392,377 -8,352 -11% $46.98 70,064 01 Feb 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GH Performance-Based Restricted Stock Units Options Exercise $0 -21,863 -100% $0.000000 0 01 Feb 2025 Common Stock 21,863 $0.000000 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the performance-based restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability.
F2 Not applicable for Performance-Based Restricted Stock Units.